Risultati per: Linea guida sullo standard di assistenza medica nel diabete
Questo è quello che abbiamo trovato per te
Linee guida ESC 2024 per la sindrome coronarica cronica
Linee guida ESC 2024 per la gestione della fibrillazione atriale
Linee guida sull’identificazione e gestione dell’insufficienza surrenalica
Sindromi coronariche, la cardiologa italiana firma le linee guida Ue
Felicita Andreotti: ‘Principale causa morte in adulti nel mondo’
Linee guida 2024 per la gestione dell’ipertensione arteriosa
Linee guida sulla terapia con ossigeno domiciliare per adulti
Sindacati, tracollo qualità assistenza nella Rsa di Ripatransone
Manca personale, problemi strutturali e tagli ai servizi
Linee guida per il trattamento dell’emofilia congenita A e B
Linee guida sulla valutazione, diagnosi, cura e supporto per le persone con demenza
Gestione dei pazienti con malattia coronarica cronica: linea guida
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort
Annals of Internal Medicine, Volume 177, Issue 9, Page 1209-1221, September 2024.
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort
Annals of Internal Medicine, Ahead of Print.
Study protocol: diagnostic accuracy study comparing Cy-Tb and STANDARD F TB-Feron FIA tests for tuberculosis infection diagnosis in Vietnam
Introduction
The large reservoir of tuberculosis (TB) infections is one of the main reasons for the persistent incidence of TB. Accurate diagnostic tests are crucial to correctly identify and treat people with TB infection, which is vital to eliminate TB globally. The rdESAT-6 and rCFP-10 (Cy-Tb) injection (‘Cy-Tb’), a TB-specific antigen skin test and STANDARD F TB-Feron FIA (‘Standard F TB’) measuring interferon-gamma by fluorescence immunoassay assay are two novel tools for the diagnosis of TB infection which offer advantages compared with current tests in low-resource settings and reduced costs to both health systems and TB-affected people. The proposed study aims to evaluate the diagnostic accuracy of these two new tests for TB infection diagnosis.
Methods and analysis
This cross-sectional study aims to assess the diagnostic accuracy for TB infection of the Cy-Tb skin test and Standard F TB assay (investigational tests) compared with the QuantiFERON-TB Gold Plus (QFT-Plus) assay as the immunological reference standard. Three different cohorts of study participants will be recruited at the Vietnam National Lung Hospital: adults with bacteriologically confirmed pulmonary TB (n=100), household contacts of people with TB (n=200) and people without TB infection (n=50). All consenting participants will undergo simultaneous testing with Cy-Tb, Standard F TB and QFT-Plus. The primary endpoint is the diagnostic accuracy of the Cy-Tb skin test and Standard F TB assay, expressed as sensitivity and specificity against the reference standard.
Ethics and dissemination
Ethical approval was granted by the Vietnam National Lung Hospital Institutional Review Board (65/23/CN-HDDD-BVPTU) and the Swedish Ethical Review Authority (Dnr 2023-04271-01). Study results will be disseminated to the scientific community and policymakers through scientific publications.
Trial registration number
NCT06221735.
Certificati e vaccini, guida per viaggiare con i propri animali
La richiesta del passaporto ai servizi veterinari delle asl